CHELSEY MOLINA: Open Payments
NPI 1689244147 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,012 in 52 payments from 13 companies in 2025. Trend: 2023 $330 · 2024 $855 · 2025 $1,012
Food & beverage: $1,012
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $255 |
| Axsome Therapeutics, Inc. | 5 | $147 |
| PFIZER INC. | 14 | $146 |
| Neurocrine BioSciences, Inc. | 1 | $139 |
| Novo Nordisk Inc | 4 | $75 |
| Lilly USA, LLC | 3 | $55 |
| SANOFI-AVENTIS U.S. LLC | 3 | $44 |
| Alexion Pharmaceuticals, Inc. | 1 | $36 |
| Averitas Pharma Inc. | 1 | $33 |
| Lundbeck LLC | 2 | $30 |
Products named: Symbravo, INGREZZA, NURTEC ODT, BOTOX, UBRELVY, TZIELD, QULIPTA, Rybelsus.
Industry payments across TN — which companies pay providers there.
